LAGANÀ, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 3.307
AS - Asia 2.112
EU - Europa 1.655
SA - Sud America 318
Continente sconosciuto - Info sul continente non disponibili 128
AF - Africa 44
OC - Oceania 4
Totale 7.568
Nazione #
US - Stati Uniti d'America 3.197
SG - Singapore 797
IT - Italia 529
CN - Cina 475
BD - Bangladesh 259
BR - Brasile 255
PL - Polonia 250
FI - Finlandia 200
HK - Hong Kong 189
VN - Vietnam 170
DE - Germania 161
GB - Regno Unito 93
FR - Francia 73
IE - Irlanda 62
TR - Turchia 60
UA - Ucraina 58
CA - Canada 57
RU - Federazione Russa 57
IN - India 43
SE - Svezia 34
NL - Olanda 32
ID - Indonesia 26
MX - Messico 26
AR - Argentina 21
CZ - Repubblica Ceca 18
ZA - Sudafrica 17
BE - Belgio 16
ES - Italia 15
IQ - Iraq 14
JP - Giappone 14
EC - Ecuador 13
AT - Austria 10
CH - Svizzera 10
PK - Pakistan 9
DZ - Algeria 8
PH - Filippine 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
SA - Arabia Saudita 7
CO - Colombia 6
CR - Costa Rica 6
HN - Honduras 6
PT - Portogallo 6
BG - Bulgaria 5
JM - Giamaica 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
LB - Libano 4
RO - Romania 4
AU - Australia 3
ET - Etiopia 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
UY - Uruguay 3
AZ - Azerbaigian 2
CY - Cipro 2
GY - Guiana 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
ZW - Zimbabwe 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 7.440
Città #
Singapore 432
Ashburn 348
San Jose 294
Dallas 249
Warsaw 246
Hong Kong 189
Helsinki 148
New York 147
Los Angeles 129
Fairfield 121
Beijing 113
Council Bluffs 98
Chandler 92
Chicago 79
The Dalles 79
Munich 62
Milan 58
Seattle 55
Ho Chi Minh City 54
Wilmington 53
Brescia 52
Columbus 51
Istanbul 46
Lauterbourg 46
Houston 45
Princeton 45
Buffalo 44
Santa Clara 43
Woodbridge 43
Dalmine 39
Jacksonville 39
Boardman 38
Cambridge 38
Turku 35
Redondo Beach 30
Secaucus 30
Shanghai 30
Hanoi 29
Dublin 28
Rome 28
Moscow 26
Jakarta 25
Dong Ket 24
Orem 24
Salt Lake City 24
Naples 23
San Francisco 23
Menlo Park 22
London 21
São Paulo 21
West Jordan 20
Bergamo 19
Des Moines 19
Poplar 18
Nuremberg 17
Ann Arbor 16
Lappeenranta 16
Atlanta 15
Brno 15
Elk Grove Village 15
Stockholm 15
Boston 14
Brooklyn 14
Brussels 14
Rio de Janeiro 14
Toronto 14
Johannesburg 13
Montreal 13
Phoenix 13
Tampa 12
Amsterdam 11
Frankfurt am Main 11
Romola 11
Pune 10
Tokyo 10
Denver 9
Manchester 9
San Diego 9
Turin 9
Biên Hòa 8
Chennai 8
Da Nang 8
Las Vegas 8
Paris 8
Tianjin 8
Bari 7
Brasília 7
Charlotte 7
Curitiba 7
Dulles 7
Düsseldorf 7
Miami 7
New Delhi 7
Sterling 7
Ankara 6
Dearborn 6
Dhaka 6
Guangzhou 6
Livorno 6
Mumbai 6
Totale 4.600
Nome #
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 384
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 259
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 230
Immunotherapy failure in adrenocortical cancer: where next? 225
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 201
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 196
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 186
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 184
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 176
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 159
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 156
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 150
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 148
Oncological treatment administration at end of life: a retrospective study 143
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 140
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 134
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 134
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 133
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 132
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 131
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 131
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 128
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 126
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 125
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 122
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 121
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 119
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 119
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 117
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 115
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 114
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 114
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 112
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 108
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 104
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 103
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 103
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 102
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 102
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 99
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 96
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 91
Adjuvant denosumab for early breast cancer-Evidence and controversy 90
The Evolving Treatment Landscape of Medullary Thyroid Cancer 87
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 85
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 84
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 80
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 79
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 78
Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort 72
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 68
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 68
Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis 59
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 58
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 54
Oligometastatic adrenocortical carcinoma: definition and treatment 52
null 51
Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen 50
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study 46
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 46
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study 44
Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis 43
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 42
The role of 2-[18F]FDG PET/CT in adrenocortical carcinoma: a systematic review 36
Quality of life questionnaire development and validation for adrenocortical carcinoma patients 35
Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases 32
Primary Adrenal Malignancies 16
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study) 13
Prolonged survival in a HER2 positive metastatic breast cancer patient with brain metastases treated with TDM1 after failure of next generation HER2 targeted therapies: case report 10
Updating ACC preclinical models: characterization of two new patient-derived cell lines 10
Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma 8
Totale 7.568
Categoria #
all - tutte 36.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022245 0 0 7 66 15 12 13 11 13 36 23 49
2022/2023249 31 16 18 15 19 51 4 27 26 8 17 17
2023/2024595 25 19 45 53 55 97 19 32 86 39 15 110
2024/20251.594 51 31 20 266 140 90 114 67 193 90 393 139
2025/20263.760 238 361 376 349 305 247 475 177 265 356 329 282
2026/2027331 159 149 23 0 0 0 0 0 0 0 0 0
Totale 7.568